BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15330122)

  • 1. Challenges in the search for an HIV vaccine.
    Lemckert AA; Goudsmit J; Barouch DH
    Eur J Epidemiol; 2004; 19(6):513-6. PubMed ID: 15330122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HIV vaccines].
    Pialoux G; Slama L
    Presse Med; 2005 Nov; 34(20 Pt 2):1592-6. PubMed ID: 16314820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of HIV vaccines.
    Graham BS
    Annu Rev Med; 2002; 53():207-21. PubMed ID: 11818471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward an HIV vaccine.
    Letvin NL
    Annu Rev Med; 2005; 56():213-23. PubMed ID: 15660510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of HIV vaccines].
    Shibata R
    Nihon Rinsho; 2002 Apr; 60(4):790-7. PubMed ID: 11968790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the correlates of protection?
    Cohen J
    Science; 1993 May; 260(5112):1259. PubMed ID: 8493565
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of prophylactic vaccines against HIV-1.
    Schiffner T; Sattentau QJ; Dorrell L
    Retrovirology; 2013 Jul; 10():72. PubMed ID: 23866844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analytic and integrative perspectives for HIV vaccine design].
    Yamamoto H
    Uirusu; 2013; 63(2):219-32. PubMed ID: 25366056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the development of an HIV-1 vaccine.
    Letvin NL
    Science; 1998 Jun; 280(5371):1875-80. PubMed ID: 9632379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection.
    Fauci AS; Gallo RC; Koenig S; Salk J; Purcell RH
    Ann Intern Med; 1989 Mar; 110(5):373-85. PubMed ID: 2464961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jitters jeopardize AIDS vaccine trials.
    Cohen J
    Science; 1993 Nov; 262(5136):980-1. PubMed ID: 8235635
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
    Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G
    J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against HIV -- back in the major leagues?
    Ferrantelli F; Ruprecht RM
    Curr Opin Immunol; 2002 Aug; 14(4):495-502. PubMed ID: 12088685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS 1989. Vaccines and immunology: overview.
    Laurence J; Schild GC
    AIDS; 1989; 3 Suppl 1():S97-100. PubMed ID: 2514762
    [No Abstract]   [Full Text] [Related]  

  • 20. Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses.
    Heeney JL
    Expert Rev Vaccines; 2004 Aug; 3(4 Suppl):S53-64. PubMed ID: 15285705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.